Skip to Main Content

Paper Details

The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.
Cell Rep
189
2015
AR, AR-negative variant, E2F, NEPC, Neuroendocrine Prostate Cancer, PEG10, Placental Gene, RB, RB1, Snail, TGF, TP53, advanced prostate cancer, androgen, androgen receptor, neuroendocrine prostate cancer, patient, placental gene PEG10, prostatic adenocarcinoma, treatment
Author NameAffiliation
Alexander W WyattUniversity of British Columbia
Dong LinUniversity of British Columbia
Fan MoUniversity of British Columbia
Anne HaegertUniversity of British Columbia
Sonal BrahmbhattUniversity of British Columbia
Robert H BellUniversity of British Columbia
Hui Xue
Ladan FazliUniversity of British Columbia
Tamara L LotanJohns Hopkins School of Medicine
Myriam KossaiWeill Cornell Medical College, USA Institute for Precision Medicine, New York Presbyterian Hospital-Weill Cornell Medical College
Juan Miguel MosqueraWeill Cornell Medical College, USA Institute for Precision Medicine, New York Presbyterian Hospital-Weill Cornell Medical College
Juan Miguel MosqueraWeill Cornell Medical College, USA Institute for Precision Medicine, New York Presbyterian Hospital-Weill Cornell Medical College
Mark A RubinWeill Cornell Medical College, USA Institute for Precision Medicine, New York Presbyterian Hospital-Weill Cornell Medical College
Mark A RubinWeill Cornell Medical College, USA Institute for Precision Medicine, New York Presbyterian Hospital-Weill Cornell Medical College
Himisha BeltranInstitute for Precision Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, Weill Cornell Medical College
Himisha BeltranInstitute for Precision Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, Weill Cornell Medical College
Amina ZoubeidiUniversity of British Columbia
Yuzhuo WangUniversity of British Columbia
Martin E GleaveUniversity of British Columbia
Colin C CollinsUniversity of British Columbia
  • 1 - 20

Datasets